- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:02 | Zeo ScientifiX, Inc.: ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians | 127 | ACCESS Newswire | DAVIE, FL / ACCESS Newswire / April 21, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX"), a provider of industry-leading clinical education in regenerative medicine innovation, proudly announces... ► Artikel lesen | |
| 12:31 | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| ZEO SCIENTIFIX Aktie jetzt für 0€ handeln | |||||
| 09.04. | Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX | 2 | CNW | ||
| 09.04. | Zeo ScientifiX, Inc.: Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX | 367 | ACCESS Newswire | Regen Therapy's 24,000-practitioner network will unlock a fully integrated care ecosystem - featuring Stealth Health's licensed prescriber team and specialized therapies, Metabolic Code-driven longevity... ► Artikel lesen | |
| 07.04. | Zeo ScientifiX, Inc.: ZEO ScientifiX Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage | 374 | ACCESS Newswire | DAVIE, FL / ACCESS Newswire / April 7, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical-stage biotechnology company, today announced its selection as a Qualified Team advancing... ► Artikel lesen | |
| 07.04. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.03. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.03. | Zeo ScientifiX, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.01. | Zeo ScientifiX, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 21.01. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.01. | ZEO ScientifiX, Inc.: Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States | 320 | ACCESS Newswire | Three-Way Collaboration to Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization Infrastructure to Patients Seeking Treatment for Non-healing Diabetic Foot... ► Artikel lesen | |
| 05.01. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10.25 | ZEO ScientifiX, Inc.: ZEO ScientifiX Positioned for New Growth as Florida Opens Stem Cell Market | 441 | ACCESS Newswire | New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance clinical research initiatives FORT LAUDERDALE, FL / ACCESS Newswire / October 23... ► Artikel lesen | |
| 23.10.25 | Zeo ScientifiX, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.07.25 | Zeo ScientifiX, Inc.: ZEO ScientifiX Positions for National Growth as Stem Cell Market Opens in Florida | 618 | ACCESS Newswire | ZEO Launches New Website and Agency Partnerships to Address Expected Biologics Market Demand Following Florida's New Stem Cell Law FORT LAUDERDALE, FL / ACCESS Newswire / July 9, 2025 / ZEO ScientifiX... ► Artikel lesen | |
| 24.06.25 | Zeo ScientifiX, Inc.: ZEO ScientifiX Launches Physician-Focused Masterclass Ahead of Florida's SB-1768 Law Implementation | 323 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESS Newswire / June 24, 2025 / ?ZEO ScientifiX, Inc.?("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company pioneering the research and development... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 35,060 | +0,31 % | BARCLAYS stuft QIAGEN NV auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Qiagen von 58 auf 44 Dollar gesenkt, aber die Aktie von "Overweight" auf "Equal Weight" abgestuft. Eine Übernahme... ► Artikel lesen | |
| BIONTECH | 93,60 | +5,05 % | Hebel-Idee | Long-Chance: Statt BioNTech oder Evotec könnte jetzt diese Biotech-Aktie eine Rallye zünden! | © Foto: Gorodenkoff / Stock.adobe.comBei der Aktie von Illumina läuft ein Turnaround auf Mehrjahresebene. Nach einer Konsolidierung besteht für Anleger jetzt wieder die Chance zum Einstieg. Willkommen... ► Artikel lesen | |
| EVOTEC | 5,685 | +0,80 % | Evotec: Aktie profitiert von Kaufempfehlung | Die Aktie von Evotec legt heute um mehr als sechs Prozent zu. Die Privatbank Berenberg sieht in der konsequenten Integration von Künstlicher Intelligenz einen entscheidenden Wachstumstreiber bei Evotec... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 26,935 | +7,23 % | UBS reiterates Buy on Summit Therapeutics stock ahead of trial data | ||
| MODERNA | 47,000 | +1,47 % | Moderna - MRNA: Impfstoff-Aktie mit mega-starkem Comeback! | + 100 Prozent in 6 Monaten! mrRNA-Impfstoffe gegen Krebs, Grippe & RSV bei Moderna in der Pipeline! Neue Rallye trotz US-Gesundheitsminister Robert F. Kennedy? Moderna (MRNA) - ISIN US60770K1079 Rückblick:... ► Artikel lesen | |
| ADMA BIOLOGICS | 11,140 | +2,30 % | Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns? | ||
| RECURSION PHARMACEUTICALS | 3,730 | +1,36 % | Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership | ||
| PSYENCE BIOMEDICAL | 9,790 | -12,67 % | Psyence Biomedical Ltd.: Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine | NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin... ► Artikel lesen | |
| ERASCA | 21,330 | -1,71 % | Erasca, Inc. - 8-K, Current Report | ||
| SENSEI BIOTHERAPEUTICS | 32,000 | 0,00 % | Leerink initiates Sensei Biotherapeutics stock at Outperform, $50 target | ||
| NUVALENT | 107,83 | -0,41 % | Nuvalent presents zidesamtinib data in pre-treated lung cancer | ||
| EDGEWISE THERAPEUTICS | 33,210 | -2,18 % | Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs | - CIRRUS-HCM 12-week data of EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) expected in H1 2026 -
- Phase 1 healthy adult trial... ► Artikel lesen | |
| SPRUCE BIOSCIENCES | 57,75 | -16,57 % | Morning Market Movers: Local Bounti, Click Holdings, SciSparc, Spruce Biosciences See Big Swings | BEIJING (dpa-AFX) - At 7:25 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| INHIBRX BIOSCIENCES | 83,60 | +1,47 % | Stifel reiterates Inhibrx Biosciences stock rating on drug potential | ||
| VALNEVA | 2,589 | -2,38 % | EILMELDUNG bei Valneva: Was große Adressen heute bereits wissen - Was Sie jetzt noch wissen müssen |
Das Unternehmen ZEO SCIENTIFIX INC kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZEO SCIENTIFIX INC finden Sie auf Wallstreet Online.